The Fund for Science and Technology announced an inaugural suite of grants and its plan to fund at least $500 million over the next four years to support transformational science and technology for people and the planet.
Mayo Clinic researchers have identified a specific immune cell that can be targeted to give a boost to standard immunotherapies for cancer. Two research teams, working collaboratively but using distinct approaches, found that “first-responder” immune cells known as myeloid cells can be manipulated to enhance the activity of tumor-killing T cells.
